Pragya Kakani

Oct 18, 2024 | aei.org | Amitabh Chandra |Pragya Kakani |Michael Kyle |Luca Maini

AbstractMedicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated rebates, and formulary coverage during the period 2011–19.

Mar 18, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Pragya Kakani

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Medicare Part D spending at in-house pharmacies rose from $324.1 million in 2011 to $1.6 billion in 2019. Researchers said evaluation of increasing financial integration among practices is “urgently” needed.